Natural recognition repertoire and the evolutionary emergence of the combinatorial immune system

The primordial combinatorial immune recognition repertoire arose in the evolution of jawed vertebrates ~450 million years ago as a rapid genetic process independent of antigenic selection. We propose that it encompassed the entire repertoire of innate immunity involving molecules that had evolved over billions of years. The ‘antigen‐driven’ compartment involving invasive pathogens operates in ‘real time’ showing inducibility and increases in affinity. Individuals within a species differ in their repertoires because of distinct antigenic challenges, genetics, or local environmental effects. The ‘homeostatic’ compartment that recognizes invariant cell and serum components should be conserved in all individuals of a species. The potential to recapitulate the entire recognition spectrum must be regenerated during the formation of new species. Evidence for the capacity of the combinatorial response to encompass the entire preexisting repertoire was obtained in studies of natural human IgG antibodies present in intravenous immunoglobulin. Since essential cellular recognition and regulatory elements are conserved throughout evolution, we propose that the natural antibodies of sharks, the most anciently emerged vertebrates to possess the combinatorial immune response, will resemble those of mammals in showing specificity for the conserved recognition/regulatory molecules. If verified, this hypothesis will establish the fundamental importance of natural antibodies not only in defense, but in regulation and functional homeostasis of the individual.—Marchalonis, J. J., Kaveri, S., Lacroix‐Desmazes, S., Kazatchkine, M. D. Natural recognition repertoire and the evolutionary emergence of the combinatorial immune system. FASEB J. 16, 842–848 (2002)

[1]  R. Good,et al.  ONTOGENY AND PHYLOGENY OF ADAPTIVE IMMUNITY. , 1964, Advances in immunology.

[2]  L. Clem,et al.  Reactivity of normal shark immunoglobulins with nitrophenyl ligands. , 1970, Journal of immunology.

[3]  M. Kay.  Mechanism of removal of senescent cells by human macrophages in situ. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Eisen,et al.  Cross-reactions between 2, 4-dinitrophenyl and menadione (vitamin K3) and the general problem of antibody specificity. , 1976, Journal of immunology.

[5]  Dual binding specificities in MOPC 384 and 870 murine myeloma immunoglobulins. , 1978, Journal of immunology.

[6]  S. Avrameas,et al.  Thirty-six human monoclonal immunoglobulins with antibody activity against cytoskeleton proteins, thyroglobulin, and native DNA: immunologic studies and clinical correlations. , 1983, Blood.

[7]  G. Litman,et al.  Major reorganization of immunoglobulin VH segmental elements during vertebrate evolution , 1986, Nature.

[8]  W. Mahana,et al.  Specificity of natural serum antibodies present in phylogenetically distinct fish species. , 1988, Immunology.

[9]  M. Kazatchkine,et al.  Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. , 1989, Journal of immunology.

[10]  J. Marchalonis,et al.  On the Relevance of Invertebrate Recognition and Defence Mechanisms to the Emergence of the Immune Response of Vertebrates , 1990, Scandinavian journal of immunology.

[11]  T. Ternynck,et al.  IgG autoantibody activity in normal mouse serum is controlled by IgM. , 1990, Journal of immunology.

[12]  J. Stewart.  Immunoglobulins did not arise in evolution to fight infection. , 1992, Immunology today.

[13]  L. Du Pasquier.  Origin and evolution of the vertebrate immune system. , 1992, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[14]  E. Sasso,et al.  VH genes in tandem array comprise a repeated germline motif. , 1992, Journal of immunology.

[15]  J. Marchalonis,et al.  Complete sequence of a cDNA clone specifying sandbar shark immunoglobulin light chain: gene organization and implications for the evolution of light chains. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Marchalonis,et al.  Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Marchalonis,et al.  Antibody production in sharks and humans: a role for natural antibodies. , 1993, Developmental and comparative immunology.

[18]  E. Sercarz,et al.  Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. , 1993, Journal of immunology.

[19]  G. Opelz,et al.  Molecular Mimicry between HIV‐1 and Antigen Receptor Molecules: A Clue to the Pathogenesis of AIDS , 1993, Vox sanguinis.

[20]  H. Ikematsu,et al.  Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidase. , 1993, International immunology.

[21]  J. Marchalonis,et al.  Autoreactive sites of human λ light chain mapped by comprehensive peptide synthesis , 1993, Journal of protein chemistry.

[22]  M. Kazatchkine,et al.  Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg) , 1993, Clinical and experimental immunology.

[23]  M. Kazatchkine,et al.  Polyreactivity is a Property of Natural and Disease‐Associated Human Autoantibodies , 1993, Scandinavian journal of immunology.

[24]  J. Marchalonis,et al.  Autoantibodies to the alpha/beta T-cell receptors in human immunodeficiency virus infection: dysregulation and mimicry. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Muyldermans,et al.  Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. , 1994, Protein engineering.

[26]  D. Klatzmann,et al.  Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg). , 1994, Therapeutic immunology.

[27]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[28]  K. Tung,et al.  Frequency of molecular mimicry among T cell peptides as the basis for autoimmune disease and autoantibody induction. , 1995, Journal of immunology.

[29]  R. Williams,et al.  Autoreactivity in HIV-1 infection: the role of molecular mimicry. , 1995, Clinical immunology and immunopathology.

[30]  A. Coutinho,et al.  Natural autoantibodies. , 1995, Current opinion in immunology.

[31]  Austin Hughes,et al.  A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks , 1995, Nature.

[32]  M. Kazatchkine,et al.  Catalytic Activity of Anti‐Thyroglobulin Antibodies a , 1995, Journal of immunology.

[33]  S. Kaveri,et al.  Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use. , 1996, The Journal of clinical investigation.

[34]  Shared V-region antigens and cross-reacting specificities of human IgG anti-F(ab')2 and anti-DNA antibodies. , 1996, Clinical immunology and immunopathology.

[35]  J. Marchalonis,et al.  Primordial emergence of the recombination activating gene 1 (RAG1): sequence of the complete shark gene indicates homology to microbial integrases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Locksley,et al.  The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.

[37]  C. Janeway,et al.  Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.

[38]  J. Marchalonis,et al.  Retrovirally Induced Mouse Anti‐TCR Monoclonals can Synergize the In Vitro Proliferative T Cell Response to Bacterial Superantigens , 1997, Scandinavian journal of immunology.

[39]  Jens Schneider-Mergener,et al.  Crystallographic Analysis of Anti-p24 (HIV-1) Monoclonal Antibody Cross-Reactivity and Polyspecificity , 1997, Cell.

[40]  Paul A. Ramsland,et al.  Diverse binding site structures revealed in homology models of polyreactive immunoglobulins , 1997, J. Comput. Aided Mol. Des..

[41]  A. Kramer,et al.  Molecular Basis for the Binding Promiscuity of an Anti-p24 (HIV-1) Monoclonal Antibody , 1997, Cell.

[42]  Binding of human IgG myeloma proteins to autologous T-cell receptor determinants. , 1997, Critical reviews in immunology.

[43]  S. Kaveri,et al.  Analysis of antibody reactivities toward self antigens of IgM of patients with Waldenström's macroglobulinemia. , 1997, International immunology.

[44]  S. Kaveri,et al.  Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease. , 1997, Blood.

[45]  J. Marchalonis,et al.  Antibodies of sharks: revolution and evolution , 1998, Immunological reviews.

[46]  H. G. Boman,et al.  Gene‐Encoded Peptide Antibiotics and the Concept of Innate Immunity: An Update Review , 1998, Scandinavian journal of immunology.

[47]  C. Wheeler,et al.  Polyreactive antigen‐binding B cells are the predominant cell type in the newborn B cell repertoire , 1998, European journal of immunology.

[48]  S. Kaveri,et al.  Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. , 1998, Journal of immunology.

[49]  S. Avrameas,et al.  Effect of amino acid substitutions in the heavy chain CDR3 of an autoantibody on its reactivity. , 1998, International immunology.

[50]  J. Tschopp,et al.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. , 1998, Science.

[51]  A. Coutinho,et al.  Self-reactive antibodies (natural autoantibodies) in healthy individuals. , 1998, Journal of immunological methods.

[52]  David G. Schatz,et al.  Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system , 1998, Nature.

[53]  A stochastic model for the rapid emergence of specific vertebrate immunity incorporating horizontal transfer of systems enabling duplication and combinational diversification. , 1998, Journal of theoretical biology.

[54]  K. Bendtzen,et al.  High-avidity autoantibodies to cytokines. , 1998, Immunology today.

[55]  R. Plasterk.  V (D)J recombination: Ragtime jumping , 1998, Nature.

[56]  M. Gellert,et al.  DNA Transposition by the RAG1 and RAG2 Proteins A Possible Source of Oncogenic Translocations , 1998, Cell.

[57]  T. Ternynck,et al.  Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. Pincus,et al.  Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen. , 1998, Journal of immunology.

[59]  J. Marchalonis,et al.  Phylogenetic emergence and molecular evolution of the immunoglobulin family. , 1998, Advances in immunology.

[60]  R. Zinkernagel,et al.  Control of early viral and bacterial distribution and disease by natural antibodies. , 1999, Science.

[61]  L. Herzenberg,et al.  Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[62]  S. Kaveri,et al.  Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg). , 1999, Blood.

[63]  J. Marchalonis,et al.  Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1. , 1999, International immunology.

[64]  J. Marchalonis,et al.  'Big Bang' emergence of the combinatorial immune system. , 1999, Developmental and comparative immunology.

[65]  J. Silver,et al.  Positive selection of natural autoreactive B cells. , 1999, Science.

[66]  J. Rast,et al.  Evolution of antigen binding receptors. , 1999, Annual review of immunology.

[67]  J. Marchalonis,et al.  Production and Characterization of Monoclonal IgM Autoantibodies Specific for the T-Cell Receptor , 2000, Journal of protein chemistry.

[68]  A. Notkins,et al.  Molecular determinants of polyreactive antibody binding: HCDR3 and cyclic peptides , 2000, Clinical and experimental immunology.

[69]  J. Marchalonis,et al.  Epitope promiscuity of human monoclonal autoantibodies to T-cell receptor-combining site determinants , 2000, Applied biochemistry and biotechnology.

[70]  M. Boes,et al.  Role of natural and immune IgM antibodies in immune responses. , 2000, Molecular immunology.

[71]  L. Pasquier.  Origin and evolution of the vertebrate immune system , 1992, Current Topics in Microbiology and Immunology.

[72]  M. Meister,et al.  The antimicrobial host defense of Drosophila. , 2000, Current topics in microbiology and immunology.

[73]  B. Diamond,et al.  Molecular Analysis of the Autoantibody Response in Peptide-Induced Autoimmunity1 , 2000, The Journal of Immunology.

[74]  T. Fahmy,et al.  Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen. , 2001, Immunity.

[75]  B. Zeitler,et al.  Evolutionary factors in the emergence of the combinatorial germline antibody repertoire. , 2001, Advances in experimental medicine and biology.

[76]  J. Marchalonis,et al.  Exquisite specificity and peptide epitope recognition promiscuity, properties shared by antibodies from sharks to humans , 2001, Journal of molecular recognition : JMR.

[77]  Piotr Kraj,et al.  αβTCRs Differ in the Degree of Their Specificity for the Positively Selecting MHC/Peptide Ligand1 , 2001, The Journal of Immunology.

[78]  S. Kaveri,et al.  Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. , 2001, The New England journal of medicine.

[79]  R. Winston,et al.  Circulating natural IgM antibodies and their corresponding human cord blood cell-derived Mabs specifically combat the Tat protein of HIV. , 2001, Experimental hematology.

[80]  Charles A. Janeway,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:How the immune system works to protect the host from infection: A personal view , 2001 .

[81]  S. Kaveri,et al.  Antibodies to C-C Chemokine Receptor 5 in Normal Human IgG Block Infection of Macrophages and Lymphocytes with Primary R5-Tropic Strains of HIV-11 , 2001, The Journal of Immunology.

[82]  P. Hudson,et al.  Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries. , 2001, Molecular immunology.

[83]  D. Schatz.  V(D)J recombination , 2002, Immunological reviews.